...
首页> 外文期刊>Veterinary Immunology and Immunopathology >Evaluation of protective efficacy of inactivated Mycoplasma synoviae vaccine with different adjuvants
【24h】

Evaluation of protective efficacy of inactivated Mycoplasma synoviae vaccine with different adjuvants

机译:不同佐剂灭活支原体疫苗疫苗保护效果的评价

获取原文
获取原文并翻译 | 示例
           

摘要

Mycoplasma synoviae (MS) is a poultry pathogen with a reported distribution throughout the world. Vaccination is utilized as an important component of MS control programs for MS infection. The aim of this study was to evaluate protection efficacy of an inactivated MS vaccine (MS bacterin) with different adjuvants in broilers against a Chinese field isolate (CHN-BZJ2-2015). Vaccination with adjuvants ISA 71 VG and chitosan, respectively, enhanced specific lymphocyte proliferation responses and upregulated the expression of IL-1 beta, IL-6, IL-2 and IFN-gamma prior to challenge. Furthermore, vaccination with adjuvant ISA 71 VG elicited the highest antibody titers, exhibited significantly lower air sac, foot pad and tracheal lesions than the other groups (P < 0.05), and decreased MS colonization. These results demonstrated that inactivated MS vaccine with ISA 71 VG is able to induce both cellular and humoral immune response in broilers and confers a high level of protection upon challenge, demonstrating a potential application in the field.
机译:支原体Synoviae(MS)是一种家禽病原体,据报道全世界。疫苗接种用作MS感染MS控制程序的重要组成部分。该研究的目的是评估灭活的MS疫苗(MS细菌)与肉鸡中的不同佐剂的保护效果,对着中国野外分离物(CHN-BZJ2-2015)。分别与佐剂ISA 71 VG和壳聚糖接种,增强了特异性淋巴细胞增殖反应,并在攻击之前上调了IL-1β,IL-6,IL-2和IFN-Gamma的表达。此外,使用佐剂ISA 71 Vg的疫苗接种引发了最高抗体滴度,显着降低的气囊,脚垫和气管病变比其他基团(P <0.05),并降低MS定植。这些结果表明,具有ISA 71 VG的灭活MS疫苗能够在肉鸡中诱导细胞和体液免疫应答,并在挑战上赋予高水平的保护,证明该领域的潜在应用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号